Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients
What You Don’t Know, You Can Selltagline Spring 2012<https://www.treatmentactiongroup.org/tagline/2012/spring/tagline/2012/spring>by Tracy SwanIn places where access to antiretroviral therapy is widespread, peopleliving with HIV are now dying from a common and curable coinfection:hepatitis C virus (HCV). HIV increases the risk for, and accelerates therate of, liver disease from hepatitis C. Pegylated interferon andribavirin, medications used to treat …
Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients Read More »